Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antibiotic Selection00:57

Antibiotic Selection

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for residual disease at re-TUR in a large cohort of T1G3 patients.

Actas urologicas espanolas·2021
Same author

Moderate hypofractionated helical tomotherapy for prostate cancer in a cohort of older patients: a mono-institutional report of toxicity and clinical outcomes.

Aging clinical and experimental research·2019
Same author

Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy.

World journal of urology·2018
Same author

Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.

World journal of urology·2018
Same author

Application of intravoxel incoherent motion (IVIM) magnetic resonance imaging in the evaluation of primitive brain tumours.

The neuroradiology journal·2017
Same author

The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcome.

Urologia internationalis·2014
Same journal

Cutaneous ureterostomy versus ileal conduit as urinary diversion in patients with muscle-invasive bladder cancer undergoing radical cystectomy: A comparative analysis of high-risk cases.

Urologia·2026
Same journal

Do we have to do ureteric reimplantation during augmentation cystoplasty in patients with spastic neurogenic bladder?

Urologia·2026
Same journal

Multiomics empowers predictive drug resistance in advanced prostate cancer.

Urologia·2026
Same journal

Spectrum of genital findings in ART-conceived male neonates: A blinded case series analyzing parental reproductive history.

Urologia·2026
Same journal

Redefining clinical success in minimally invasive surgery for BPH: A composite endpoint integrating ejaculatory function, urinary improvement, and safety metrics.

Urologia·2026
Same journal

A randomized controlled trial on the impact of bovhyaluronidase azoximer on ejaculate biofilms in patients with chronic prostatitis.

Urologia·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
05:32

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection

Published on: September 21, 2015

[Antibiotic prophylaxis in prostate biopsy].

V Serretta1, A Catanese, A Ruggirello

  • 1Dipartimento di Medicina Interna Malattie Cardiovascolari e Nefrourologiche, Sezione di Urologia, Università degli Studi di Palermo.

Urologia
|October 5, 2010
PubMed
Summary
This summary is machine-generated.

Antibiotic prophylaxis is recommended for transrectal prostate biopsies to prevent infections. Tailoring prophylaxis based on patient risk and procedure type can reduce complication rates, making it a cost-effective strategy.

More Related Videos

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Related Experiment Videos

Last Updated: Jun 8, 2026

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
05:32

Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection

Published on: September 21, 2015

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Area of Science:

  • Urology
  • Infectious Disease Prevention
  • Pharmacology

Context:

  • Prostate biopsy is a common urological procedure.
  • Transrectal prostate biopsy carries a higher risk of infectious complications than transperineal.
  • Antibiotic prophylaxis is widely used to mitigate these risks, particularly for transrectal procedures.

Purpose:

  • To review current practices and recommendations for antibiotic prophylaxis in prostate biopsies.
  • To discuss the factors influencing antibiotic choice, timing, and efficacy.
  • To emphasize the importance of tailoring prophylaxis to patient risk and procedure type.

Summary:

  • Antibiotic prophylaxis is crucial for reducing infection rates after transrectal prostate biopsies, aiming for rates below 5%.
  • Optimal prophylaxis involves considering patient infective risk, the specific biopsy route (transrectal vs. transperineal), and potentially using broad-spectrum antibiotics.
  • Commonly, a 1-3 day course of fluoroquinolones is used, though single-dose regimens show promise. Factors like tolerability, cost, and route of administration are also important.

Impact:

  • Implementing appropriate antibiotic prophylaxis can significantly decrease the incidence of post-biopsy infections.
  • This preventative measure is cost-effective when compared to the expenses associated with treating serious infectious complications.
  • Guidelines recommend prophylaxis for high-risk patients and all transrectal prostate biopsy cases.